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Introduction
In 2012, about 14 million new cases of cancer were reported 
worldwide [1]. Due to a variety of new therapies, especially targeted 
treatment approaches, survival has improved substantially in recent 
years [2]. However, cancer itself and its medical treatment are 
accompanied by a number of treatment-related adverse effects and 
toxicities including detrimental effects on physical, psychological and 
social aspects [3]. An important and clinical side-effect has often been 
termed as “chemobrain” [3], which describes cognitive dysfunction 
associated to cancer treatment [4,5]. This broad term includes a 
variety of cognitive impairments that may occur either temporarily 
or persist as a long-term consequence of treatment [3,6-8]. Cognitive 
dysfunction mainly relates to memory, attention, executive functions, 
learning and speed of information processing decline [4,5,9]. Further, 
it is also known that other factors than cancer treatments influence the 
development of cognitive changes in cancer patients suggesting that 
this is a multifactorial process [3,10]. As a result, experts have proposed 
the term “cancer-related cognitive impairments” (CRCI) which we will 
use hereinafter [11]. 
It has been suggested the percentage of patient suffering from 
CRCI varies between 16% to 75% depending on type of treatment (e.g. 
chemotherapy, radiation) and time point of measurement (before, 
during or after medical treatment) [3], also affecting patients ‘quality 
of life [12].
The purpose of this narrative review is to present a descriptive 
overview of the multifactorial process of CRCI in cancer patients and 
the impact of physical inactivity during this process. Numerous studies 
have reviewed the effects of physical activity on health; however, few 
studies are available on physical inactivity or sedentary behavior [13].
Physical activity appears to decrease from time of cancer diagnosis 
to initiation of anticancer treatment with patients showing the lowest 
levels during treatment with a subsequent increase following therapy 
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Abstract
Many cancer survivors report cognitive impairment before, during and after medical treatment. It is well 
known that many factors other than chemotherapy take part in the development of these cancer- related cognitive 
impairments (CRCI), such as cancer-related fatigue, psychological as well as molecular factors. The purpose of this 
review is to describe the impact of physical inactivity in the genesis of these cognitive changes in cancer patients. 
References for this narrative review comes primarily from PubMed, Cochrane Library and Livivo databases. It 
contains literature search from October 2003 to April 2016. Our search was focused on available data for the 
influence of physical inactivity on cognitive performance of cancer patients. Cancer patients have decreased levels 
of physical activity during treatment. It is suggested that lack of physical activity in general is associated with 
cognitive decline. At present, most available data comes from trials with heart failure patients as well as results from 
bed rest studies in space medicine. The development of CRCI is a multifactorial process with physical inactivity 
appearing to play an important role. However, the available data remains limited and future trials are needed to 
examine the specific role of physical inactivity on CRCI.
[14-16]. The role of physical inactivity in the multifactorial process of 
CRCI development has not been extensively described and is the focus 
of our review (Figure 1).
Materials and Methods
This narrative review has been divided into four sections: 1) 
multifactorial aspects generating CRCI, 2) the role of physical inactivity, 
3) discussion, and 4) conclusion. Information from this narrative review 
was obtained by searching the PubMed, Livivo and Cochrane Library 
databases from October 2003 to June 2016. A first search focuses 
on the influence of physical inactivity on development of cognitive 
impairments in cancer patients. Therefore, a combination of following 
terms was used: on the one hand “cancer-related cognitive decline”, 
“cancer-related cognitive dysfunctions”, “cancer-related cognitive 
impairments”, “chemobrain”, “chemofog”, “post-chemotherapy 
cognitive impairment”, “cancer brain”, “cancer associated cognitive 
impairment”, “cancer-therapy-associated cognitive impairment” and 
on the other hand “bed rest”, “immobilization”, “lack of exercise”, 
“physical inactivity”. There were no publications referring to this 
aspect exclusively. As such, a second search was conducted focusing 
on influence of physical inactivity on cognitive performance in general. 
Therefore, a combination of the following terms was used: “physical 
inactivity”, “bed rest”, “immobilization”, “lack of exercise” and on the 
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changes might be associated with impaired memory performance 
and difficulties in learning [4,5,22-27]. In rodent research, it is also 
reported that cytostatic agents (e.g. carmustine, cytarabine, cisplatin, 
5-FU, MTX) affect the oligodendrocytes which may lead to damage 
of the white matter [21,24,26-28] hence potentially reducing speed 
of information processing [27]. Furthermore, cytostatic therapy 
induces reduction of the gray matter in certain brain areas, such as 
the cerebellum and the prefrontal cortex. Loss of gray matter density 
seems to be associated with impairment in executive functions, verbal 
memory und working memory [9,19,29]. 
Several anti-tumor therapies also appear to lead to alterations 
in cerebral blood flow. For example, some medical treatments 
induce cerebral hyperperfusion accompanied by impairment in 
neuropsychological test performance. In contrary, a decrease of 
gray matter density in those brain areas is associated with cerebral 
hypoperfusion [20]. 
Hormone therapy
CRCI may even occur after hormone therapy (e.g. tamoxifen, 
aromatase inhibitors, androgen deprivation therapy) [3,9,10]. 
other hand “cognition” “cognitive decline”, “memory”, “attention”, 
“learning”, “executive functions”. As a result, six relevant articles were 
found in total. For background information concerning development 
or treatment of CRCI we also used information from Google Scholar 
database. Finally, data from world cancer report 2014 and American 
Association for Cancer Research were included in this review [1].
Multifactorial Aspects Generating CRCI
In past years, CRCI was placed at the center of numerous clinical 
trials (e.g. by Hermelink et al. [18], Lepage et al. [19], Nudelman et al. 
[20], Wefel et al. [7] and Whitney et al. [8]), particularly in patients 
with breast cancer, and also in some rodent-based research (e.g. by 
Briones et al. [4], Han et al. [21] and Seigers et al. [22-24]). 
Chemotherapeutics
Several studies have shown that chemotherapeutics negatively 
impacts on a variety of ways the central nervous system functions. For 
example, cytostatic agents such as cyclophosphamide, 5-flouracil (5-
FU), doxorubicin and methotrexate (MTX) have shown to decrease 
neurogenesis and/or cell proliferation in the hippocampus. These 
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Figure 1: Impact of physical inactivity on “Cancer Related Cognitive Impairments (CRCI)” in a multifactorial genesis.
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Consequently, androgen deprivation therapy seems to be associated 
with a reduced response time considering to cognitive function [3]. 
Tamoxifen is an estrogen receptor antagonist and its use is accompanied 
by impaired cognitive capabilities [3]. Aromatase inhibitors intervene 
in the estrogen metabolism by blocking the conversion of androgens 
to estrogens resulting in reduced levels of estrogen and leading to 
cognitive impairments [3].
Radiation therapy
Research undertaken with animal models has suggested that cranial 
radiation decreases neurogenesis in the hippocampus which leads to 
impaired hippocampal memory functions [30]. It has been suggested 
that irradiation doses of a least 5 Gray (Gy) are sufficient to induce 
these changes [30]. Furthermore, it is assumed that radiation-induced 
neuroinflammation is associated with hippocampal dysfunction [30]. 
Among other factors oxidative stress and proinflammatory cytokines 
such as tumor necrosis factor α (TNF-α) and interleukin-1β (IL-1β) 
are involved in these inflammatory processes leading to neuronal 
impairments (e.g. through affecting mitochondrial functions). As a 
result, survival and differentiation of neural progenitor cells can be 
negatively affected. Finally, decrease of hippocampal neurogenesis is 
also induced [30].
Brain- derived neurotrophic factor (BDNF) is an important 
modulator in the context of the proliferation, differentiation and 
survival of cerebral neurons. Moreover, it seems to take a significant 
role in hippocampus dependent learning and memory processes. 
Cerebral irradiation leads to a decrease of the BDNF levels in the serum 
associated with disruption of these processes [30]. Furthermore, data 
from animal research suggests an association between low levels of 
BDNF and the emergence of depressive symptoms [30].
Molecular underspinning mechanisms
On a molecular level some inflammatory cytokines such as IL-1, 
IL-6 and TNF-α seem to take part on the genesis of CRCI [2]. It is well 
documented that an increased BMI which can be driven by a sedentary 
lifestyle contributes to elevated PR inflammatory cytokine levels. A 
prospective cohort study with breast cancer patients staged I-III have 
shown impairment of speed performance in patients with increased 
serum levels of IL-1β and poorer verbal memory in patients with 
increased levels of TNF-α. An increased level of IL- 6 seems to favor a 
rise of self- perceived cognitive impairment. In contrast, higher serum 
levels of IL- 4 were associated with improvement in speed performance 
[31]. A positive relationship has been reported between higher serum 
levels of IL-6 and an increase of cancer- related fatigue [32]. Increased 
levels of several inflammatory cytokines appear to be a consequence of 
both cancer itself and anticancer treatment [3,31]. 
Furthermore, it is suspected that the tumor itself may negatively 
affect cognitive function in different ways [10,27]. Among other aspects, 
it is suggested that presence of cancer is accompanied by reduced levels 
of BDNF. There might also be an association with damaged DNA and 
damaged repair mechanisms of DNA [27,33].
As mentioned above, studies investigating the relationship between 
physical inactivity and CRCI are sparse. However, exercise intervention 
studies in both, humans and animals suggest that physical activity 
induces an anti-inflammatory cytokine profile, e.g. by increasing 
the number of IL-10 releasing regulatory T-cells and by reducing 
fat mass [34,35]. Additionally, physical activity induces a number of 
neuroprotective and neurotrophic factors such as BDNF, VEGF, IGF-1 
and 5-HT [36]. Interestingly, such increase impact both peripheral and 
central concentrations of the named factors [37].
Patient-associated factors
It is also proposed that there are patient-associated factors like 
genetic predisposition or changes in hormonal status (e.g. decreased 
levels of neuroprotective estrogen) which favor the development 
of CRCI [3,29]. Among several aspects, risk for developing CRCI 
seems to be associated with genotype of catechol o- methyltransferase 
(COMT) thereby where the gene coding for this enzyme is located on 
chromosome 22q11. At codon 158 either valine and / or methionine 
are incorporated. Depending on the installed amino acid, COMT 
is modified in its function by the breakdown of dopamine in the 
prefrontal cortex. If valine is located on this place degradation takes 
3-4x. As a result, CRCI appears to be more pronounced in valine 
carriers than in methionine carriers [10,38,39]. Moreover, cancer 
patients with the allele e4 of the apolipoproteine E (ApoEe4) have 
an increased risk in developing CRCI. For example, Koleck et al. 
have shown in a prospective, longitudinal study that cancer patients 
with ApoEe4 have worse results in verbal learning and memory than 
controls [39]. ApoEe4 is also often present in patients suffering from 
Alzheimer’s disease [3,29]. 
Psychological factors
CRCI can be divided into self- perceived and objective-measured 
cognitive impairments. They may not necessarily have to appear 
together in cancer patients suffering from cognitive changes [18]. 
Subjectively perceived cognitive impairments correlates with fatigue, 
extent of depression and level of negative attitude of the patient [3,18]. 
Interestingly, in some patients CRCI is present before the initiation 
of anticancer treatment [40,41]. Wefel et al. suggested an association 
between level of patient’s distress and this phenomenon [40]. Data on 
the prospective “Cognicare study” by Hermelink et al. also indicated 
cancer-related posttraumatic stress as an important causal factor for 
pretreatment cognitive decline [41]. 
Lifestyle Factors
Severity of CRCI is likely to also be dependent on lifestyle factors. 
Hartmann et al. described decreases of cognitive performance to be 
associated with sleep deprivation in women with breast cancer. Moreover, 
higher levels of physical activity appear to prevent CRCI [42].
Physical inactivity and CRCI 
Several clinical trials with cancer patients have shown that physical 
activity decreases after diagnosis [14-16,43,44]. For instance, physical 
inactivity is associated with a decrease of hippocampal neurogenesis 
and loss of hippocampal volume, and this may result in cognitive 
impairment [45]. This leads to memory impairment and problems 
in decision-making. Inactivity is also associated with a decreased 
neurogenesis in the cerebellum, inducing problems in motor programs, 
and in the olfactory bulb [45]. Alosco et al. described a loss of gray matter 
volume and cortical thickness in patients with poor physical fitness in 
patients with heart failure. Importantly, the authors have suggested that 
such changes were not caused by cardiac disease or any other medical 
conditions [46]. In a longitudinal trial with 65 heart failure patients, 
Alosco et al. concluded that physical inactivity is closely associated with 
cerebral hypoperfusion. Reduced blood flow seems to have a negative 
effect especially on executive functions and attention [47]. Lipnicki et 
al. has also found a negative effect on executive functions and a delayed 
reaction time by 60 days of head-down bed rest [48]. Similarly, Liu et al. 
provided similar conclusions in their head-down bed rest- experiments 
[49]. However, results from bed rest studies concerning the influence 
on cognitive performance are inconsist with some studies reporting an 
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improvement in cognitive performance, others reporting no significant 
effect and some reporting a detrimental effect [50]. These findings were 
independent of bed rest position and have been found in different types 
of cognition tests [50].
As described above, similarities between developing CRCI and the 
impact of physical inactivity on cognitive performance in general exist. 
Both lack of exercise and cancer treatment lead to alterations in cerebral 
blood flow associated with impairment in attention and executive 
function [20,47]. Further, they both induce partly comparable changes 
in brain structures like loss of gray matter in some brain regions 
[9,19,29,46]. Moreover, both lack of exercise and several anticancer 
treatments (chemotherapeutic agents, radiation) lead to a decreased 
hippocampal neurogenesis and hippocampal volume [29,46]. These 
changes are associated with memory impairment and problems in 
decision making [4,5,22-25,27,45].
Exacerbation of fatigue, depression and anxiety favor the 
development of self- reported cognitive impairments in cancer patients 
[3,6,18]. Lack of exercise is also associated with an increased risk for 
fatigue and depression [51], which may consequently reduce the ability 
to exercise [52]. Further, data from clinical trials concerning the effect 
of physical activity on CRCI shows an improvement of self- reported 
cognitive impairment [53,54]. There might also be a positive effect 
on verbal memory, attention and function of frontal brain [55,56]. 
Moreover, levels of IL-1β, IL-6 and TNF-α are lower in patients 
engaging in regular exercise [54,57].
Discussion
The development of CRCI is a multifactorial process. In addition 
to anticancer treatment numerous other factors such as depression, 
anxiety, patient-associated factors, molecular factors, tumor itself and 
cancer-related fatigue takes part in this process [3,10,27]. As a result 
of the above mentioned communalities between CRCI’s genesis and 
influence of physical inactivity on cognitive performance in general, 
we also suggest that physical inactivity is another important causative 
factor of CRCI. However, data concerning influence of physical 
inactivity on cognitive performance are limited and are primarily from 
studies in patients with heart failure or from bed rest studies in space 
medicine [46-50].
Despite numerous clinical trials and some rodent research in the 
last years, the phenomenon of CRCI is not yet fully understood. Current 
data suggests that especially anthracycline- based chemotherapeutic-
regimes have a negative effect on verbal memory performance and 
left precuneus connectivity [58]. Furthermore, the exact influence 
of hormone therapies is still unknown and therefore their exact role 
remains to be determined [3]. In addition, knowledge about the side 
effects of antibody therapy on cognitive impairment is very weak [59]. 
Moreover, currently data on the influence of psychological factors on 
development of CRCI differs among studies [3,7,18]. 
Due to the large number of potential causative factors different 
treatment strategies exists to address CRCI. Time from active treatment 
seems to be one of the most important factors in the regression of CRCI 
as most patients’ cognitive performance improves over the time [60]. 
Pharmacological treatment options are available but unfortunately are 
not well supported by clinical data [3,61]. Psychological intervention 
can also take place in treatment of mood disorders and cancer- 
related fatigue [62,63]. In addition, other interventions such as skill-
focused cognitive training seem to improve executive functions, 
memory functions, and speed of information processing [64]. Physical 
exercise intervention studies have also shown good efficacy in the 
management of CRCI [11,54-57,64,65]. Amongst several positive 
effects, improvement of verbal memory, attention and prefrontal 
lobe functions have been reported [55,56]. Physical exercise seems to 
also decrease level of proinflammatory cytokines like IL-6, IL-1β and 
TNF-α as well as levels of inflammation in general in humans [52,57]. 
Moreover, physical exercise leads to improvement in self- perceived 
cognitive impairment and quality of life [53,54,57]. Although drawing 
similar conclusions, results from these studies must be critically 
interpreted due to methodological limitations and small sample sizes. 
Further randomized controlled studies with larger sample sizes are 
required to confirm and expand current preliminary findings. 
Conclusion
The development of CRCI is a multifactorial process. In this 
narrative review, we provided the multifactorial genesis of CRCI and 
particularly the role of physical inactivity in this context. Existing data 
on changes of physical activity levels in cancer patients and its associated 
effects on CRCI remains limited. Future trials are encouraged to focus 
on these aspects to confirm and expand current findings. Importantly, 
the influence of physical inactivity on development of CRCI needs to 
be determined via randomized- controlled trials. 
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